Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Clinical trial NCT05651022 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05651022
Sponsor: Indaptus Therapeutics, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult HCC - Hepatocellular Carcinoma CRC (Colorectal Cancer)Pancreatic Adenocarcinoma NSCLC Non-small Cell Lung Cancer Squamous Cell Cancer of the Head and Neck UC (Urothelial Cancer)MSI-H Cancer

Start date: 2023-02-28
Primary completion: 2027-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.